When Antidepressants Stop Working, There Is Still a Next Step

Most people living with depression have been told the same things. Try this medication. Give it six weeks. If it doesn't work, try a different one. Adjust the dose. Add another. And somewhere in that cycle, hope starts to feel like a luxury you can't afford.

If that sounds familiar, you are not out of options. You may just not have found the right one yet. At Ketamine Wellness Infusions PA, located minutes from Lower Merion Township in Bala Cynwyd, we offer IV ketamine infusions for depression that has not responded to conventional treatment. It works through a completely different mechanism than every antidepressant you have likely tried. It works faster. And for many of our patients, it works when nothing else has.

Our founder, Jill Gabay, is a senior CRNA with more than 30 years of anesthesia experience and a member of the American Society of Ketamine Physicians, Psychotherapists and Practitioners. She is present for every infusion, every patient, every time. We hold a 5.0 Google rating from patients who arrived skeptical and left with their lives changed.

Schedule a consultation and find out if IV ketamine is the right depression treatment for you.

What Makes Depression So Difficult to Treat

Depression is not a single thing. It is a family of conditions with overlapping symptoms, different biological underpinnings, and wildly variable responses to the same medications. Two people with identical diagnoses can respond completely differently to the same antidepressant, and neither response tells you anything definitive about the other.

Standard antidepressants, SSRIs and SNRIs primarily, work by increasing the availability of serotonin or norepinephrine in the brain. For many people, that adjustment provides meaningful relief. But roughly one in three people with major depression do not achieve adequate remission with their first antidepressant. A significant portion of those people cycle through multiple medications over months or years without ever finding one that works well enough.

There is also the timeline problem. Most antidepressants require four to six weeks before any therapeutic effect becomes apparent. That is six weeks of side effects, six weeks of waiting, and for someone in the depths of a major depressive episode, six weeks can feel unsurvivable.

This is the clinical reality that IV ketamine was developed to address.

How IV Ketamine Treats Depression Differently

Ketamine does not touch the serotonin system. That distinction matters enormously.

Instead of altering neurotransmitter reuptake, ketamine targets the brain's glutamate system by binding to NMDA receptors and triggering a cascade of neurological events. It promotes the release of brain-derived neurotrophic factor, or BDNF, which stimulates the growth of new synaptic connections in areas of the brain that depression tends to shrink and damage over time. Specifically, research has shown that depression reduces gray matter volume in the prefrontal cortex and hippocampus. Ketamine helps reverse that structural damage by promoting neuroplasticity, the brain's capacity to form new pathways and reorganize itself.

The practical result is relief that arrives in hours, not weeks. Many patients report a meaningful shift in mood during or shortly after their first infusion. Some describe it as the first time in months or years that the weight of depression felt genuinely lighter.

Studies conducted at Yale University and the National Institute of Mental Health have documented ketamine's rapid antidepressant effects in patients who had not responded to conventional treatments. It is now widely considered the most significant development in depression pharmacology in the past 50 years.

At our Bala Cynwyd clinic, we administer IV ketamine at dissociative psychiatric dosing levels, the same protocol used in clinical research and recommended for mood disorder treatment. This is a higher, more targeted dose than pain management infusions, and it requires the experienced clinical oversight that Jill Gabay brings to every session.

Types of Depression We Treat with IV Ketamine

Major Depressive Disorder

Major depressive disorder is characterized by persistent low mood, loss of interest or pleasure in activities, fatigue, cognitive changes, and physical symptoms that last for two weeks or more and meaningfully impair daily functioning. It is the most common serious mental health condition in the United States, affecting more than 20 million adults annually. When standard treatments have not produced adequate relief, IV ketamine offers a pathway that works through an entirely different mechanism, often producing results within the first one or two infusions.

Treatment-Resistant Depression

Treatment-resistant depression is formally defined as depression that has not responded adequately to at least two different antidepressant medications at therapeutic doses and durations. It is more common than most people realize. If you have been in this cycle, IV ketamine was specifically researched and validated for exactly your situation. The clinical evidence is strong, and our patients consistently confirm it.

Persistent Depressive Disorder (Dysthymia)

Persistent depressive disorder is a lower-grade but unrelenting form of depression that lasts for two or more years. It is quieter than major depression but no less damaging, gradually eroding energy, motivation, relationships, and quality of life over time. Because the symptoms are less dramatic, it often goes undertreated for years. Ketamine's rapid neuroplasticity effects can interrupt the chronically depressed baseline that dysthymia creates.

Postpartum Depression

Postpartum depression affects a meaningful percentage of people after childbirth and can make what should be a meaningful time feel isolating, frightening, and overwhelming. Standard antidepressants often underperform for this presentation, and the stakes of an inadequate treatment response are especially high when a new parent is involved. IV ketamine offers faster relief and a different clinical mechanism, and we approach this condition with particular care and sensitivity.

Seasonal Affective Disorder (SAD)

Seasonal affective disorder creates a predictable but exhausting cycle of depression tied to the shorter days of fall and winter. For people who have not found adequate relief through light therapy or antidepressants, IV ketamine offers a faster-acting alternative that can provide meaningful relief before or during the worst months of the season.

Psychotic Depression

Severe major depression presenting with psychotic features, such as hallucinations, delusions, or profoundly distorted thinking, requires experienced clinical management and rarely responds to standard antidepressants alone. Jill Gabay's deep background in anesthesia and psychiatric-level dosing makes our clinic an appropriate and safe setting for complex presentations like this one.

What the Treatment Process Looks Like

Starting ketamine therapy for depression at our clinic is a straightforward process designed around your comfort and safety.

Your first step is a consultation. We review your medical and psychiatric history in detail, discuss your previous treatment experiences, and determine whether IV ketamine is an appropriate fit for your specific situation. There is no pressure and no assumption that this is the right path for everyone. If it is not the right fit, we will tell you.

If you move forward, your treatment course consists of six IV ketamine infusions, typically spaced over two to three weeks. Each infusion session lasts approximately 40 to 60 minutes. You will be in a calm, comfortable room with blankets, an eye mask, and an essential oil diffuser. Jill or a member of our care team is present and monitoring your vital signs throughout every session. You will not be alone.

During the infusion, many patients experience mild dissociation, altered perception of time, or vivid but manageable sensory changes. This is the ketamine working as intended. The experience is temporary and resolves quickly after the infusion ends. Most patients find it tolerable once they know what to expect, and many describe subsequent sessions as deeply relaxing.

After your infusion series, Jill conducts personal follow-up check-ins to assess your response and discuss next steps. Some patients maintain relief for months following their initial series. Others benefit from periodic maintenance infusions. Your ongoing plan is based entirely on how you respond.

Why Lower Merion Township Patients Choose Our Clinic

Bala Cynwyd sits at the center of Lower Merion Township, and our clinic at 146 Montgomery Ave is easily accessible from Ardmore, Wynnewood, Narberth, Penn Valley, Bryn Mawr, and throughout the Main Line. You do not need to drive into Philadelphia for this level of care.

What distinguishes our clinic is not just proximity. It is the clinical depth Jill Gabay brings to psychiatric-level dosing, the physician oversight provided by Dr. Rubin, a board-certified oncologist and Clinical Associate Professor at Drexel University College of Medicine, and the personal, unhurried attention every patient receives from consultation through completion of their treatment series.

Fellow ketamine clinicians have praised Jill specifically for her expertise in psychiatric-level dosing. That is not marketing language. It is a reflection of 30 or more years spent mastering the pharmacology and clinical management that IV ketamine requires when administered for mental health conditions.

Our patients consistently describe the clinic as clean, peaceful, and professional. More than that, they describe feeling genuinely seen and cared for, often after years of feeling like just another chart in a revolving door of psychiatric appointments.

Frequently Asked Questions About Depression Treatment in Lower Merion Township